Human Monoclonal Antibody MBL-HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study-Reference-Cited by-同舟云学术

Human Monoclonal Antibody MBL-HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study

Published:2013-01-28 Issue:4 Volume:13 Page:1047-1054
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Chung R. T.¹,Gordon F. D.²,Curry M. P.³,Schiano T. D.⁴,Emre S.⁵,Corey K.¹,Markmann J. F.¹,Hertl M.¹,Pomposelli J. J.²,Pomfret E. A.²,Florman S.⁴,Schilsky M.⁵,Broering T. J.⁶,Finberg R. W.⁷,Szabo G.⁷,Zamore P. D.⁸,Khettry U.²,Babcock G. J.⁶,Ambrosino D. M.⁶,Leav B.⁶,Leney M.⁶,Smith H. L.⁶,Molrine D. C.⁶

Affiliation:

1. Department of Transplant Surgery, Massachusetts General Hospital; Boston MA

2. Department of Transplantation, Lahey Clinic Medical Center; Burlington MA

3. Beth Israel Deaconess Medical Center; Boston MA

4. Department of Surgery, Mount Sinai Medical Center; New York NY

5. Department of Medicine, Yale New Haven Hospital; New Haven CT

6. MassBiologics; University of Massachusetts Medical School; Boston MA

7. Department of Medicine; University of Massachusetts Medical School; Worcester MA

8. Howard Hughes Medical Institute and Department of Biochemistry & Molecular Pharmacology; University of Massachusetts Medical School; Worcester MA

Funder

MassBiologics, University of Massachusetts

NIH